Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Tanaka

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
New developments in macrolides: structures and antibacterial and prokinetic activitiesP A Lartey, H N Nellans, S K Tanaka
New Jersey Medicine : the Journal of the Medical Society of New Jersey|January 1, 1986
Aztreonam: preclinical studiesD P Bonner, S K Tanaka, R A Schwind
The Journal of Antimicrobial Chemotherapy|October 1, 1996
Kill kinetics of antimicrobial agents against Helicobacter pyloriR K Flamm, J Beyer, S K Tanaka, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1985
Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacaeK Bush, S K Tanaka, D P Bonner, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1996
Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritisJ A Meulbroek, A Oleksijew, S K Tanaka, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1988
Inactivation of beta-lactamases from Enterobacter cloacae by monophosphamsK Bush, S A Smith, S K Tanaka, et al.
Journal of Clinical Microbiology|June 1, 1997
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pHA M Nilius, J M Beyer, R K Flamm, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1987
Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coliK Bush, S A Smith, S Ohringer, et al.
Diagnostic Microbiology and Infectious Disease|October 1, 1996
Novel mechanism of macrolide resistance in Streptococcus pneumoniaeV D Shortridge, R K Flamm, N Ramer, et al.
The Journal of Antibiotics|December 1, 1988
Lysobactin, a novel antibacterial agent produced by Lysobacter sp. II. Biological propertiesD P Bonner, J O'Sullivan, S K Tanaka, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Advances in Pharmacology (San Diego, Calif.)|January 1, 1994
New developments in macrolides: structures and antibacterial and prokinetic activitiesP A Lartey, H N Nellans, S K Tanaka
New Jersey Medicine : the Journal of the Medical Society of New Jersey|January 1, 1986
Aztreonam: preclinical studiesD P Bonner, S K Tanaka, R A Schwind
The Journal of Antimicrobial Chemotherapy|October 1, 1996
Kill kinetics of antimicrobial agents against Helicobacter pyloriR K Flamm, J Beyer, S K Tanaka, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1985
Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacaeK Bush, S K Tanaka, D P Bonner, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1996
Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritisJ A Meulbroek, A Oleksijew, S K Tanaka, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1988
Inactivation of beta-lactamases from Enterobacter cloacae by monophosphamsK Bush, S A Smith, S K Tanaka, et al.
Journal of Clinical Microbiology|June 1, 1997
Variability in susceptibilities of Haemophilus influenzae to clarithromycin and azithromycin due to medium pHA M Nilius, J M Beyer, R K Flamm, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1987
Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coliK Bush, S A Smith, S Ohringer, et al.
Diagnostic Microbiology and Infectious Disease|October 1, 1996
Novel mechanism of macrolide resistance in Streptococcus pneumoniaeV D Shortridge, R K Flamm, N Ramer, et al.
The Journal of Antibiotics|December 1, 1988
Lysobactin, a novel antibacterial agent produced by Lysobacter sp. II. Biological propertiesD P Bonner, J O'Sullivan, S K Tanaka, et al.
Pageof 4